Remove 2027 Remove COVID-19 Remove COVID-19 Vaccine
article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027. First, we look at the macro picture on health services utilization comparing the end of 2022 with pre-COVID-19 levels.

article thumbnail

Skilled Nursing Update: CMS Finalizes Changes to SNF Value-Based Purchasing, SNF Quality Reporting Program and Civil Monetary Penalties

Hall Render

CMS is also adopting the COVID Vaccine: Percent of Patients/Residents Who Are Up to Date (known as the “Patient/Resident COVID-19 Vaccine”) measure beginning with the FY 2026. The Discharge Function Score measure beginning with the FY 2027 program year and FY 2025 performance year.

Nurses 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Skilled Nursing Update: CMS Proposes Changes to SNF Value-Based Purchasing, SNF Quality Reporting Program and Civil Monetary Penalties

Hall Render

CMS is also proposing the adoption of the COVID Vaccine: Percent of Patients/Residents Who Are Up to Date (known as the “Patient/Resident COVID-19 Vaccine”) measure beginning with the fiscal year 2026. This measure assesses the hospitalization rate of long-stay residents.

Nurses 40
article thumbnail

Future Trends and Regulatory Challenges in Pharma

Dot Compliance

The race to develop a COVID-19 vaccine highlighted the power of artificial intelligence (AI) and machine learning (ML) as Johnson & Johnson, Moderna and Pfizer employed these technologies to swiftly get their vaccines to market. The next evolution is for companies to implement Industry 4.0 References.

article thumbnail

February 2022 State Regulatory Developments

New Jersey Healthcare Blog

For 2023 the healthcare cost growth benchmark is 3.5%, for 2024 3.2%, for 2025 3%, for 2026 2.8%, for 2027 2.8%. Additionally, this order extends several regulatory actions taken by the Departments in response to COVID-19, including various waivers. 199(b), the Office of the Governor restated Executive Order No. At 54 N.J.R.

article thumbnail

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA

Commission Extends Transparency and Authorization Mechanism for Exports of COVID-19 Vaccines, 11 March 2021. The EC has extended until the end of June 2021 the transparency and authorization mechanism for COVID-19 vaccine exports. The EU continues to be the leading provider of vaccines around the world.

article thumbnail

Health Provider News

Hall Render

Supreme Court won’t hear COVID vaccine case filed by N.J. Million Individuals Affected by MOVEit Hack MARYLAND Adventist HealthCare, Montgomery College form partnership to address need for qualified nursing workforce Harford Memorial Hospital closing set for Feb. hospitals Prospect Medical Holdings has underfunded two R.I.